Cambridge Investment Research Advisors
CTRE icon

Cambridge Investment Research Advisors’s CareTrust REIT CTRE Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CTRE Stock Details CTRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.33M Sell
57,801
-1,586
-3% -$62.3K 0.01% 1563
2026
Q1 		$2.18M Buy
59,387
+1,580
+3% +$60.7K 0.01% 1524
2025
Q4 		$2.09M Buy
57,807
+5,539
+11% +$199K 0.01% 1481
2025
Q3 		$1.81M Buy
52,268
+943
+2% +$31K 0.01% 1578
2025
Q2 		$1.57M Buy
51,325
+2,830
+6% +$81.6K ﹤0.01% 1612
2025
Q1 		$1.39M Buy
48,495
+3,626
+8% +$97.4K ﹤0.01% 1608
2024
Q4 		$1.21M Buy
44,869
+33,194
+284% +$992K ﹤0.01% 1721
2024
Q3 		$360K Sell
11,675
-3,474
-23% -$98.4K ﹤0.01% 2685
2024
Q2 		$380K Sell
15,149
-1,192
-7% -$29.5K ﹤0.01% 2511
2024
Q1 		$398K Sell
16,341
-3,656
-18% -$82.5K ﹤0.01% 2474
2023
Q4 		$448K Buy
19,997
+49
+0.2% +$1.08K ﹤0.01% 2275
2023
Q3 		$409K Buy
19,948
+254
+1% +$5.14K ﹤0.01% 2250
2023
Q2 		$391K Buy
19,694
+1,793
+10% +$35K ﹤0.01% 2320
2023
Q1 		$351K Buy
17,901
+368
+2% +$7.2K ﹤0.01% 2346
2022
Q4 		$326K Sell
17,533
-89
-0.5% -$1.66K ﹤0.01% 2368
2022
Q3 		$319K Sell
17,622
-2,366
-12% -$48.2K ﹤0.01% 2312
2022
Q2 		$369K Sell
19,988
-1,356
-6% -$24K ﹤0.01% 2191
2022
Q1 		$412K Buy
21,344
+300
+1% +$5.91K ﹤0.01% 2265
2021
Q4 		$480K Sell
21,044
-582
-3% -$12.3K ﹤0.01% 2134
2021
Q3 		$439K Buy
21,626
+1,138
+6% +$25.7K ﹤0.01% 2144
2021
Q2 		$476K Buy
+20,488
New +$482K ﹤0.01% 2093
2020
Q2 		– Sell
-13,068
Closed -$193K – 2464
2020
Q1 		$193K Sell
13,068
-10,456
-44% -$207K ﹤0.01% 1951
2019
Q4 		$485K Buy
23,524
+14,597
+164% +$319K ﹤0.01% 1602
2019
Q3 		$210K Sell
8,927
-1,471
-14% -$34.5K ﹤0.01% 2078
2019
Q2 		$247K Sell
10,398
-22,920
-69% -$555K ﹤0.01% 1872
2019
Q1 		$782K Buy
+33,318
New +$730K 0.01% 1178

Other funds holding CTRE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Cohen & Steers
Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Cambridge Investment Research Advisors's CTRE Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its CareTrust REIT (CTRE) stake by 2.7% in Q2 2026, selling an estimated $62.3K and leaving 57,801 shares worth $2.33M. The position accounts for 0.01% of the portfolio, ranked #1563.

Cambridge Investment Research Advisors first reported a position in CTRE in Q1 2019 and has held it in 26 quarters since. 512 funds tracked by Wall St. Rank hold CTRE as of Q2 2026.

  • Cambridge Investment Research Advisors held 57,801 shares of CareTrust REIT worth $2.33M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 1,586 CareTrust REIT shares in Q2 2026, an estimated $62.3K.
  • CareTrust REIT made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1563 holding.
  • Cambridge Investment Research Advisors first reported a position in CareTrust REIT in Q1 2019 and has held it in 26 quarters since.
  • 512 funds tracked by Wall St. Rank held CareTrust REIT as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.